Manufacturer-Perceived Development and Market-Entry Risks Associated with Discontinuation and Non-launch of Generic Medicines in Japan: A Cross-Sectional Survey of Marketing Authorization Holders

Hiroaki Mamiya, Harumi Tagoku, Ken-ichi Izutsu

Open source

DOI
10.1007/s40290-026-00636-8
Published
2026-09-14
Container
Pharmaceutical Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40290-026-00636-8,
  title = {Manufacturer-Perceived Development and Market-Entry Risks Associated with Discontinuation and Non-launch of Generic Medicines in Japan: A Cross-Sectional Survey of Marketing Authorization Holders},
  author = {Hiroaki Mamiya and Harumi Tagoku and Ken-ichi Izutsu},
  year = {2026},
  journal = {Pharmaceutical Medicine},
  doi = {10.1007/s40290-026-00636-8},
  url = {https://doi.org/10.1007/s40290-026-00636-8}
}

RIS

TY  - JOUR
TI  - Manufacturer-Perceived Development and Market-Entry Risks Associated with Discontinuation and Non-launch of Generic Medicines in Japan: A Cross-Sectional Survey of Marketing Authorization Holders
AU  - Hiroaki Mamiya
AU  - Harumi Tagoku
AU  - Ken-ichi Izutsu
PY  - 2026
JO  - Pharmaceutical Medicine
DO  - 10.1007/s40290-026-00636-8
UR  - https://doi.org/10.1007/s40290-026-00636-8
ER  - 

APA

Mamiya, H., Tagoku, H., & Izutsu, K. (2026). Manufacturer-Perceived Development and Market-Entry Risks Associated with Discontinuation and Non-launch of Generic Medicines in Japan: A Cross-Sectional Survey of Marketing Authorization Holders. Pharmaceutical Medicine. https://doi.org/10.1007/s40290-026-00636-8

Source records